Repository navigation
v0.4.0
SYNAPTIK v0.4.0: In Silico Antisense Oligonucleotide (ASO) Engineering Engine
This release marks a major translational leap, transforming SYNAPTIK into an active drug-design engine for neurological diseases.
Highlights
-
In Silico ASO Engineering Pipeline (\synaptik aso):
- Automatically engineers clinical-grade antisense oligonucleotides for splice-switching (SSO, steric hindrance for cryptic exon exclusion or exon inclusion) and RNase H1-mediated transcript degradation (gapmers).
- Nearest-neighbor thermodynamic duplex modeling (
$\Delta H^\circ$ ,$\Delta S^\circ$ ,$\Delta G_{37}^\circ$ ,$) under physiological CSF conditions ($ [Na^+]=100\text{ mM}, [C_T]=250\text{ nM}$) with empirical 2'-MOE thermal stabilization ($+1.1^\circ\text{C}$ /nt), matching clinical empirical data within .6^\circ\text{C}$ (e.g. Nusinersen \approx 64.5^\circ\text{C}$). - Biophysical liability filters detecting G-quadruplexes (
$\ge 4$ Gs; neurotoxicity risk), poly-T/U tracts, secondary hairpins ($\Delta G_{\text{hairpin}}$ ), and 3'-end self-dimerization. - Neural transcriptome off-target screening against core housekeeping and neuronal genes (ACTB, GAPDH, TUBB3, MAP2, SYP, SNAP25, TARDBP, FUS, SOD1, C9orf72), enforcing zero 0-mismatch or 1-mismatch off-target hits.
- Synthesis-ready output: Molecular weight (sodium salt), extinction coefficient
$\epsilon_{260}$ , predicted human CSF terminal half-life (~135 days), and orderable IDT vendor format strings (\mN*...).
-
Comprehensive Quality Assurance:
- Dedicated test suite \ ests/test_aso.py\ with 20 new checks (257 checks total across the platform).
- 100% CI pass rate across Python 3.10, 3.11, and 3.12.